Related Experiment Videos
Neurologic complications of immunosuppressive agents
1Cornell University Medical College, New York, New York.
Neurologic Clinics
|May 1, 1988
Summary
Immunosuppressive drugs used in organ transplantation can cause direct neurologic complications. As transplant success grows, more patients may experience this drug-induced neurotoxicity.
Area of Science:
- Immunology
- Neurology
- Pharmacology
Background:
- Immunosuppressive agents are crucial for preventing organ graft rejection and graft-versus-host disease (GVHD).
- Common immunosuppressants include Cyclosporine A (CsA), corticosteroids, OKT3 monoclonal antibody, HDARA-C, azathioprine, and anti-thymocyte globulin (ATG).
Purpose of the Study:
- To identify immunosuppressive agents with direct neurotoxic potential in organ transplantation.
- To highlight the increasing incidence of neurologic complications associated with these drugs.
Main Methods:
- Review of literature on immunosuppressive agents used in organ transplantation.
- Analysis of reported adverse events, specifically neurologic complications.
Main Results:
- Cyclosporine A (CsA), corticosteroids, OKT3 monoclonal antibody, and HDARA-C are associated with direct neurologic complications.
- Azathioprine and ATG do not appear to have direct neurotoxic effects, with complications likely due to excessive immune suppression.
Conclusions:
- Several key immunosuppressants carry a risk of direct neurologic toxicity independent of immune suppression levels.
- Increased patient survival in transplantation necessitates greater awareness and monitoring for drug-induced neurologic complications.